CT83 and cancer: To assess the functional avidity of CT83/TCR1, we performed experiments for T2/A11 stimulation loaded with a titrated concentration of cognate peptides, the recognition of several solid tumor cell lines and the cytotoxicity of three representative cancer cell lines with CT83/TCR1-T cells.